Neuland Laboratories Ltd Share Price ₹17,198

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Neuland Laboratories Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	407	363	418	393	385	440	311	398	328	293	514	440	776
Expenses +	287	266	280	272	278	316	249	311	277	258	359	363	469
Operating Profit	120	97	137	121	107	123	62	87	51	34	156	77	307
OPM %	29%	27%	33%	31%	28%	28%	20%	22%	16%	12%	30%	18%	40%
Other Income +	8	2	3	2	5	25	4	60	7	8	2	8	12
Interest	4	2	4	4	4	3	1	2	2	5	5	7	7
Depreciation	13	14	15	15	16	16	16	16	17	20	23	24	25
Profit before tax	110	83	122	104	92	130	49	128	39	18	129	54	287
Tax %	23%	26%	27%	22%	27%	25%	34%	20%	29%	21%	25%	26%	26%
Net Profit +	85	62	89	81	68	98	33	102	28	14	97	41	213
EPS in Rs	65.89	48.23	69.56	63.44	52.66	76.28	25.60	79.18	21.68	10.83	75.49	31.62	165.76

Financials of Neuland Laboratories Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	469	510	579	527	667	763	937	951	1,191	1,559	1,477	2,023
Expenses +	402	430	472	477	608	661	790	807	918	1,096	1,146	1,448
Operating Profit	67	80	106	51	58	102	147	144	273	463	331	574
OPM %	14%	16%	18%	10%	9%	13%	16%	15%	23%	30%	22%	28%
Other Income +	0	2	1	4	3	4	16	0	9	12	90	30
Interest	27	24	21	19	16	22	18	14	13	14	8	24
Depreciation	15	16	19	22	26	31	40	49	53	60	66	92
Profit before tax	25	42	67	14	20	53	105	82	216	401	346	489
Tax %	36%	36%	30%	13%	19%	69%	23%	22%	24%	25%	25%	26%
Net Profit +	16	27	47	12	16	16	81	64	164	300	260	364
EPS in Rs	17.96	30.75	52.74	13.57	12.81	12.63	62.85	49.74	127.45	233.89	202.74	283.71
Dividend Payout %	8%	7%	0%	0%	0%	16%	8%	10%	8%	6%	6%	12%

Financials of Neuland Laboratories Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9	9	9	9	13	13	13	13	13	13	13	13
Reserves	152	178	537	549	686	697	774	828	981	1,270	1,512	1,862
Borrowings +	188	182	192	319	231	264	182	241	128	95	157	301
Other Liabilities +	162	155	148	194	200	257	356	302	457	454	498	754
Total Liabilities	512	524	886	1,071	1,130	1,231	1,325	1,383	1,580	1,833	2,180	2,930
Fixed Assets +	123	139	466	475	542	653	716	767	758	824	955	1,178
CWIP	41	40	20	126	104	24	17	20	41	46	48	210
Investments	7	7	8	8	8	8	7	4	1	1	109	2
Other Assets +	340	337	393	463	476	547	585	592	781	962	1,068	1,541
Total Assets	512	524	886	1,071	1,130	1,231	1,325	1,383	1,580	1,833	2,180	2,930

Financials of Neuland Laboratories Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	13	45	39	11	70	57	189	60	237	261	317	347
Cash from Investing Activity +	-14	-20	-42	-116	-77	-49	-84	-95	-61	-150	-298	-424
Cash from Financing Activity +	1	-24	-0	105	12	-5	-114	38	-136	-69	25	21
Net Cash Flow	0	1	-4	-0	5	3	-9	3	40	42	44	-56
Free Cash Flow	-1	26	-2	-121	7	9	84	-37	173	119	112	-50
CFO/OP	33%	70%	52%	28%	128%	61%	132%	56%	103%	81%	119%	78%

Financials of Neuland Laboratories Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	100	85	114	134	90	91	85	90	111	87	78	98
Inventory Days	170	182	186	266	191	209	205	227	211	220	238	247
Days Payable	167	121	118	189	118	110	126	100	129	121	156	130
Cash Conversion Cycle	103	147	182	211	162	190	164	216	193	187	160	214
Working Capital Days	11	26	44	38	138	137	60	74	81	88	76	75
ROCE %	16%	18%	16%	4%	4%	8%	11%	10%	21%	33%	19%	27%